Urinary Extracellular Vesicle: A Potential Source of Early Diagnostic and Therapeutic Biomarker in Diabetic Kidney Disease

Overview

Journal Chin Med J (Engl)

Specialty General Medicine

Date 2018 May 23

PMID 29786051

Citations 12

Authors

Wei-Cheng Xu

Ge Qian

Ai-Qun Liu

Yong-Qiang Li

He-Qun Zou

Affiliations

Soon will be listed here.

Abstract

Objective: Diabetic kidney disease (DKD) has become one of the major causes of end-stage renal disease. Urinary extracellular vesicles (uEVs) contain rich biological information which could be the ideal source for noninvasive biomarkers of DKD. This review discussed the potential early diagnostic and therapeutic values of proteins and microRNAs in uEVs in DKD.

Data Sources: This review was based articles published in PubMed, Embase, Cochrane, and Google Scholar databases up to November 20, 2017, with the following keywords: "Diabetic kidney disease", "Extracellular vesicle", and "Urine".

Study Selection: Relevant articles were carefully reviewed, with no exclusions applied to the study design and publication type.

Results: There is no "gold standard" technology to separate and/or purify uEVs. The uEVs contain a variety of proteins and RNAs and participate in the physiological and pathological processes of the kidney. UEVs, especially urinary exosomes, may be useful biomarkers for early diagnosis and treatment to DKD. Furthermore, the uEVs has been used as a therapeutic target for DKD.

Conclusion: Proteins and nucleic acids in uEVs represent promising biomarker for the diagnosis and treatment of DKD.

Citing Articles

Unveiling the functional paradigm of exosome-derived long non-coding RNAs (lncRNAs) in cancer: based on a narrative review and systematic review.

Wu W, He J J Cancer Res Clin Oncol. 2023; 149(16):15219-15247.

PMID: 37578522 DOI: 10.1007/s00432-023-05273-1.

An optimized method for the isolation of urinary extracellular vesicles for molecular phenotyping: detection of biomarkers for radiation exposure.

Hinzman C, Jayatilake M, Bansal S, Fish B, Li Y, Zhang Y J Transl Med. 2022; 20(1):199.

PMID: 35538547 PMC: 9092707. DOI: 10.1186/s12967-022-03414-7.

Review on Strategies and Technologies for Exosome Isolation and Purification.

Chen J, Li P, Zhang T, Xu Z, Huang X, Wang R Front Bioeng Biotechnol. 2022; 9:811971.

PMID: 35071216 PMC: 8766409. DOI: 10.3389/fbioe.2021.811971.

MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy.

Yun J, Ren J, Liu Y, Dai L, Song L, Ma X Bioengineered. 2021; 13(1):634-644.

PMID: 34898373 PMC: 8805927. DOI: 10.1080/21655979.2021.2012548.

Exosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications.

Chen A, Wang H, Su Y, Zhang C, Qiu Y, Zhou Y Front Endocrinol (Lausanne). 2021; 12:720466.

PMID: 34456875 PMC: 8387814. DOI: 10.3389/fendo.2021.720466.

References

Damke H, Baba T, van der Bliek A, Schmid S . Clathrin-independent pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of dynamin. J Cell Biol. 1995; 131(1):69-80. PMC: 2120592. DOI: 10.1083/jcb.131.1.69. View

Sun H, Yao W, Tang Y, Zhuang W, Wu D, Huang S . Urinary exosomes as a novel biomarker for evaluation of α-lipoic acid's protective effect in early diabetic nephropathy. J Clin Lab Anal. 2017; 31(6). PMC: 6816889. DOI: 10.1002/jcla.22129. View

Zubiri I, Posada-Ayala M, Sanz-Maroto A, Calvo E, Martin-Lorenzo M, Gonzalez-Calero L . Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. J Proteomics. 2013; 96:92-102. DOI: 10.1016/j.jprot.2013.10.037. View

Admyre C, Johansson S, Qazi K, Filen J, Lahesmaa R, Norman M . Exosomes with immune modulatory features are present in human breast milk. J Immunol. 2007; 179(3):1969-78. DOI: 10.4049/jimmunol.179.3.1969. View

Shankar J, Boscher C, Nabi I . Caveolin-1, galectin-3 and lipid raft domains in cancer cell signalling. Essays Biochem. 2015; 57:189-201. DOI: 10.1042/bse0570189. View

Sun Y, Koo S, White N, Peralta E, Esau C, Dean N . Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 2004; 32(22):e188. PMC: 545483. DOI: 10.1093/nar/gnh186. View

Ogawa Y, Kanai-Azuma M, Akimoto Y, Kawakami H, Yanoshita R . Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull. 2008; 31(6):1059-62. DOI: 10.1248/bpb.31.1059. View

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

Wang Z, Wu H, Fine D, Schmulen J, Hu Y, Godin B . Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip. 2013; 13(15):2879-82. PMC: 3740541. DOI: 10.1039/c3lc41343h. View

10.

Miranda K, Bond D, McKee M, Skog J, Paunescu T, da Silva N . Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010; 78(2):191-9. PMC: 4451567. DOI: 10.1038/ki.2010.106. View

11.

Chang T, Mendell J . microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet. 2007; 8:215-39. DOI: 10.1146/annurev.genom.8.080706.092351. View

12.

Karpman D, Stahl A, Arvidsson I . Extracellular vesicles in renal disease. Nat Rev Nephrol. 2017; 13(9):545-562. DOI: 10.1038/nrneph.2017.98. View

13.

Hogan M, Manganelli L, Woollard J, Masyuk A, Masyuk T, Tammachote R . Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol. 2009; 20(2):278-88. PMC: 2637052. DOI: 10.1681/ASN.2008060564. View

14.

. Erratum. Microvascular Complications and Foot Care. Sec. 10. In . Diabetes Care 2017;40(Suppl. 1);S88-S98. Diabetes Care. 2017; 40(7):986. PMC: 5481974. DOI: 10.2337/dc17-er07c. View

15.

Cheruvanky A, Zhou H, Pisitkun T, Kopp J, Knepper M, Yuen P . Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol. 2007; 292(5):F1657-61. PMC: 2271070. DOI: 10.1152/ajprenal.00434.2006. View

16.

Davies R, Kim J, Jang S, Choi E, Gho Y, Park J . Microfluidic filtration system to isolate extracellular vesicles from blood. Lab Chip. 2012; 12(24):5202-10. DOI: 10.1039/c2lc41006k. View

17.

Musante L, Tataruch-Weinert D, Kerjaschki D, Henry M, Meleady P, Holthofer H . Residual urinary extracellular vesicles in ultracentrifugation supernatants after hydrostatic filtration dialysis enrichment. J Extracell Vesicles. 2017; 6(1):1267896. PMC: 5328348. DOI: 10.1080/20013078.2016.1267896. View

18.

Sun A, Deng J, Guan G, Chen S, Liu Y, Cheng J . Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease. Diab Vasc Dis Res. 2012; 9(4):301-8. DOI: 10.1177/1479164111434318. View

19.

Wu M, Ouyang Y, Wang Z, Zhang R, Huang P, Chen C . Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci U S A. 2017; 114(40):10584-10589. PMC: 5635903. DOI: 10.1073/pnas.1709210114. View

20.

Burger D, Thibodeau J, Holterman C, Burns K, Touyz R, Kennedy C . Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury. J Am Soc Nephrol. 2014; 25(7):1401-7. PMC: 4073432. DOI: 10.1681/ASN.2013070763. View